Sara Rundquist
6PUBLICATIONS
8CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (6)
Sort by Publication Date:
|Jul 12, 2024
Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease: Results From Nationwide Swedish Registers.Sara Karlqvist, Michael C Sachs, Carl Eriksson
|Dec 19, 2020
Drug survival of anti-TNF agents compared with vedolizumab as a second-line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers.Sara Rundquist, Michael C Sachs, Carl Eriksson
|Oct 25, 2018
Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).Sara Rundquist, Carl Eriksson, Linda Nilsson
Pageof 1
